Department of Medical Oncology, Harvard University, Cambridge, MA 02138, United States
Commentary
PARP Inhibitors: Revolution, Resistance, Future Strategies
Author(s): David Miller*
DOI:
10.37421/1948-5956.2025.17.713
Cancer Science & Therapy received 5332 citations as per Google Scholar report